Should I Buy MENS? MENS 2026 Analysis

Should You Buy Jyong Biotech Ltd (MENS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

2.560

1 Day change

1.19%

52 Week Range

67.000

Analysis Updated At

2026/01/26

Based on the available data, Jyong Biotech Ltd (MENS) is not a strong buy for a beginner investor with a long-term strategy at this time. The technical indicators show bearish trends, and there are no significant positive catalysts or trading signals to support an immediate buy decision. The lack of financial data, news, and analyst ratings further limits the ability to justify a strong investment case.

Technical Analysis

The MACD is above 0 but positively contracting, indicating waning bullish momentum. The RSI is neutral at 20.749, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near a key support level (S1: 3.071), with resistance levels at R1: 3.911 and R2: 4.171.

Options Data

Positive Catalysts

NULL identified. No recent news, significant trading trends, or congress trading data available.

Neutral/Negative Catalysts

Bearish moving averages and lack of positive momentum in technical indicators. No significant insider or hedge fund activity. No recent news or financial data to support growth.

Financial Performance

No financial data available for analysis.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst ratings or price target changes available.

Analyst Rating

Wall Street analysts forecast MENS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MENS is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold

Sell

Current: 2.530

Low

Averages

High